A detailed history of Fora Capital, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Fora Capital, LLC holds 5,081 shares of IONS stock, worth $191,452. This represents 0.03% of its overall portfolio holdings.

Number of Shares
5,081
Holding current value
$191,452
% of portfolio
0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$40.06 - $51.86 $203,544 - $263,500
5,081 New
5,081 $203,000
Q2 2022

Aug 11, 2022

SELL
$31.71 - $43.0 $193,272 - $262,085
-6,095 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$29.88 - $37.04 $182,118 - $225,758
6,095 New
6,095 $218,000
Q3 2020

Nov 13, 2020

SELL
$47.45 - $62.95 $229,563 - $304,552
-4,838 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$46.85 - $61.05 $226,660 - $295,359
4,838 New
4,838 $285 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.35B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Fora Capital, LLC Portfolio

Follow Fora Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fora Capital, LLC with notifications on news.